Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based Chemotherapy

BACKGROUND: The National Comprehensive Cancer Network and American Society of Clinical Oncology recommend consideration of the use of echocardiography 6-12 months after completion of anthracycline-based chemotherapy in at risk populations. Assessment of brain natriuretic peptide (BNP) has also been...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Circ Cardiovasc Qual Outcomes
Glavni autori: Ruddy, Kathryn J., Sangaralingham, Lindsey R., Van Houten, Holly, Nowsheen, Somaira, Sandhu, Nicole, Moslehi, Javid, Neuman, Heather, Jemal, Ahmedin, Haddad, Tufia C., Blaes, Anne H., Villarraga, Hector R., Thompson, Carrie, Shah, Nilay D., Herrmann, Joerg
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7101030/
https://ncbi.nlm.nih.gov/pubmed/32106704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.119.005984
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items